Navigation Links
Chocolate bar shown to lower cholesterol
Date:4/21/2008

The results of a University of Illinois study have demonstrated an effective way to lower cholesterol levels by eating chocolate bars.

Eating two CocoaVia dark chocolate bars a day not only lowered cholesterol, it had the unexpected effect of also lowering systolic blood pressure, said John Erdman, a U. of I. professor of food science and human nutrition.

The study, funded in part by Mars Inc., the company that makes the bars, was published in this months Journal of Nutrition.

Erdman attributes the drop in cholesterol numbers (total cholesterol by 2 percent and LDL or bad cholesterol by 5.3 percent) to the plant sterols that have been added to the bar and the drop in blood pressure to the flavanols found in dark chocolate.

Erdman says that some people will assume the study is flawed because of Mars funding role.

I know that it was a double-blinded trial that wasnt skewed toward a particular result, said Erdman, who chairs the Mars Scientific Advisory Council. Moreover, the paper was peer-reviewed and published in the Journal of Nutrition, which ranks in the top 10 percent of all the biological science journals. Mars has spent millions of dollars studying the biological impact of the flavanols found in cocoa beans and learning how to retain their benefits during the refining process, Erdman said.

Forty-nine persons with slightly elevated cholesterol and normal blood pressure were recruited for the study. Those chosen for the double-blind, placebo-controlled, cross-over study began the American Heart Associations Eating Plan for Healthy Americans (formerly the Step 1 diet) two weeks before the study started; then they were divided into two matched groups. Two types of CocoaVia bars were then introduced, one with plant sterols and one without.

While remaining on the AHA diet, participants ate one CocoaVia formulation twice daily for four weeks, then switched to the other bar for an additional four wee
'/>"/>

Contact: Phyllis Picklesimer
p-pickle@uiuc.edu
217-244-2827
University of Illinois at Urbana-Champaign
Source:Eurekalert

Page: 1 2

Related biology news :

1. New test could help consumers avoid surprise headaches from chocolate, wine
2. Eat chocolate, drink wine, add fun to life: SLU geriatrician shares secrets of staying young
3. Spaceflight shown to alter ability of bacteria to cause disease
4. DNA methylation shown to promote development of colon tumors
5. Student study bolsters case for adding a rare sunflower to the endangered species list
6. Eating competence may lower risk of heart disease
7. Student study bolsters case for adding a rare sunflower to the endangered species list
8. Recovery from acid rain much slower than expected
9. Folic acid lowers blood arsenic levels, according to Mailman School of Public Health study
10. Study finds that even aloof husbands have lower testosterone levels than unmarried men
11. Folic acid lowers blood arsenic levels in Bangladesh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/18/2012)... clears the mind. It gets the blood pumping and ... familiar territory, but Dartmouth,s David Bucci thinks there is ... years there have been data suggesting that neurobiological changes ... here," says Bucci, an associate professor in the Department ... Bucci and his collaborators have revealed important new findings: ...
(Date:5/17/2012)... increasing opportunities to participate in genetic testing that ... a disease. Receiving these results does not appreciably ... potentially costly follow-up health services, according to a ... of Health and colleagues at other institutions. , ... online issue of Genetics in Medicine ...
(Date:5/17/2012)... May 17th 2012. Wiley-Blackwell, the scientific, technical, medical ... Inc., today announced the launch of Food Science ... Access publishing program. The journal will provide authors with ... latest research and will be published in collaboration with ... Science & Technology and other prominent societies. , ...
Breaking Biology News(10 mins):Dartmouth researchers are learning how exercise affects the brain 2Dartmouth researchers are learning how exercise affects the brain 3NIH-led study finds genetic test results do not trigger increased use of health services 2NIH-led study finds genetic test results do not trigger increased use of health services 3NIH-led study finds genetic test results do not trigger increased use of health services 4Wiley-Blackwell launches new open-access journal: Food Science & Nutrition 2Black Liver Cancer Patients Face Worst Odds 65074 1Black Liver Cancer Patients Face Worst Odds 65074 2GNC Becomes a Presenting Sponsor for the Pittsburgh Health 26amp 3B Fitness Expo of the Dicks Sporting Goods Pittsburgh Marathon 65070 1GNC Becomes a Presenting Sponsor for the Pittsburgh Health 26amp 3B Fitness Expo of the Dicks Sporting Goods Pittsburgh Marathon 65070 2GNC Becomes a Presenting Sponsor for the Pittsburgh Health 26amp 3B Fitness Expo of the Dicks Sporting Goods Pittsburgh Marathon 65070 3 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 1 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 2 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 3 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 4 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 5 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 6 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 7 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 8 C6terna Zentaris Partner Keryx Reports a Statistically Significant Benefit in Survival from Updated Results of a Randomized Double Blind Placebo Co 15396 9
... to the public and press on Wednesday 14 to Friday ... 5:15pm, Wednesday 14th November , Where: Owen Glenn Building, Wynyard ... be launched with a public symposium on Wednesday 14 November. ... on other days by arrangement. , With evidence in hand ...
... the most serious threats to child health in developing ... groundbreaking work by an international consortium led by the ... grant from the Bill & Melinda Gates Foundation. , ... easy-to-use diagnostic tool giving a clear, reliable indication of ...
... major study that will provide a new window into ... the La Jolla Institute for Allergy & Immunology (LIAI) ... study, funded by the National Institute of Allergy and ... Health, could lead to revolutionary new approaches for treating ...
Other Biology News:How much fish have we got? 2How much fish have we got? 3Life-saving clean water project secures $13M from Bill & Melinda Gates Foundation 2NIH selects LIAI for major study on allergy molecular causes and possible treatments 2NIH selects LIAI for major study on allergy molecular causes and possible treatments 3NIH selects LIAI for major study on allergy molecular causes and possible treatments 4
(Date:5/16/2012)... YORK, May 16, 2012 ... research report is available in its ... Industry http://www.reportlinker.com/p090668/Global-Biotechnology-Instrumentation-Industry.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_ ... worldwide markets for Biotechnology Instrumentation in ... Segments: DNA Synthesizers, Protein/Peptide Synthesizers, DNA ...
(Date:5/16/2012)... May 16, 2012  MultiCell Technologies, Inc. ... is pleased to announce representatives from the ... MCT-465 and MCT-485 at CIMT 2012 ( ... cancer immunotherapy research and development.  CIMT 2012 ... Mainz, Germany.  The title of the poster ...
(Date:5/15/2012)... Vermillion, Inc. (NASDAQ: VRML ), a leading ... the first quarter ended March 31, 2012. ... the volume of OVA1®, the company,s flagship diagnostic test ... was generally in line with the forecast set by ... 28% to 3,952 from the same year-ago quarter. ...
(Date:5/15/2012)... -- Cardium Therapeutics (NYSE Amex: CXM ... first quarter ended March 31, 2012, and other ... In addition to the announcement ... its goals for 2012, which were outlined in ... advance commercialization of its new Excellagen® advanced, physician-use ...
Breaking Biology Technology:Global Biotechnology Instrumentation Industry 2Global Biotechnology Instrumentation Industry 3Global Biotechnology Instrumentation Industry 4Global Biotechnology Instrumentation Industry 5Global Biotechnology Instrumentation Industry 6Global Biotechnology Instrumentation Industry 7Global Biotechnology Instrumentation Industry 8Global Biotechnology Instrumentation Industry 9Global Biotechnology Instrumentation Industry 10Global Biotechnology Instrumentation Industry 11Global Biotechnology Instrumentation Industry 12Global Biotechnology Instrumentation Industry 13Global Biotechnology Instrumentation Industry 14Global Biotechnology Instrumentation Industry 15Global Biotechnology Instrumentation Industry 16Global Biotechnology Instrumentation Industry 17Global Biotechnology Instrumentation Industry 18Global Biotechnology Instrumentation Industry 19Global Biotechnology Instrumentation Industry 20MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 2MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 3MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 4MultiCell Technologies Announces Positive Preclinical Results for MCT-465 and MCT-485 in Primary Liver Cancer In Vitro Models 5Vermillion Reports First Quarter 2012 Results 2Vermillion Reports First Quarter 2012 Results 3Vermillion Reports First Quarter 2012 Results 4Vermillion Reports First Quarter 2012 Results 5Vermillion Reports First Quarter 2012 Results 6Vermillion Reports First Quarter 2012 Results 7Vermillion Reports First Quarter 2012 Results 8Cardium Presents First Quarter 2012 Financial Results and Recent Developments 2Cardium Presents First Quarter 2012 Financial Results and Recent Developments 3Cardium Presents First Quarter 2012 Financial Results and Recent Developments 4Cardium Presents First Quarter 2012 Financial Results and Recent Developments 5Cardium Presents First Quarter 2012 Financial Results and Recent Developments 6
... Inc., the pioneer,in scalable, high performance cell loading ... Demonstration of the MaxCyte STX Scalable,Transfection System on ... the,A/C/T Assays & Cellular Targets Conference in San ... Vice President of Research and,Development at MaxCyte, "The ...
... has,announced the launch of a new "Nursing School" section ... portal section is designed to assist,nursing school educators in ... assist students with research promoting patient safety,patient handling and ... is a pro bono injury prevention,site designed to help ...
... Helix BioPharma announced,today that Dr. Heman Chao, ... be presenting L-DOS47 research findings at the National,Research ... of the,Genomics and Health Initiative, today in Saskatoon, ... the NRC, government,departments and private industry and covers ...
Other Biology Technology:MaxCyte Debuts the STX Scalable Transfection System at the A/C/T Assays & Cellular Targets Meeting 2New Safe Lifting Patient Safety Resource for Nursing School Educators and Students 2Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canada's Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada 2Helix BioPharma to Present L-DOS47 Research Findings at the National Research Council of Canada's Eighth Annual General Meeting of the Genomics and Health Initiative in Saskatoon, Canada 3
BD BioCoat Fibronectin 35 mm Culture Dishes, tissue-culture treated polystyrene with a uniform application of human fibronectin....
... CLS number is a new product ... product number. If showing no availability ... Sigma-Aldrich number (C6671) or contact customer ... yes Surface area 148 cm 2 ...
... The CHEMICON XpressPack™ Colorimetric Detection System is ... of amplified DNA generated by an in-house ... a selected target of interest. ... Detection System is a hybridization capture assay ...
... is optimized for maximum packaging efficiencies of cDNA ... l vector. Using a test insert with Novagen's ... (> 4 x 10^8 pfu/g ligated l control ... extremely easy to use; simply add up to ...
Biology Products: